Back to Agenda
Session 22: Interactions with FDA - Part 1
Session Chair(s)
Michael Hamrell, PhD, RAC
President
MORIAH Consultants, United States
- FDA’s guidance on meetings
- Time course of events in requesting and preparing for a meeting
- Objectives and conduct of specific meetings with FDA
Have an account?